Skip to main content
NIH funding notice PA-14-059

Small Business Technology Transfer Research (STTR) to Develop New Diagnostic, Monitoring and Therapeutics Technologies for the Complications of Type 1 Diabetes (T1D) [STTR (R41/R42)]

Closed on January 7, 2017.

Posted
January 3, 2014
Close date
January 7, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $369,879 in first-year total cost, median $184,940.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MOSS-D (10)]1
  2. Special Emphasis Panel[ZRG1 MOSS-V (15)]1

Most frequent institutions

  1. INFRARED RX, INC.1
  2. PROSTHETIC DESIGN, INC.1
Competing awards under PA-14-059 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring1R41DK112497-01MCCULLY, KEVIN K.INFRARED RX, INC., GA$183,142ZRG1
2016Carbon Fiber Off-Loading Orthosis1R41DK109731-01HASTINGS, MARY KPROSTHETIC DESIGN, INC., MO$186,737ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.